These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 25082520

  • 21. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
    Masters GA, Hoffman PC, Drinkard LC, Watson S, Samuels BL, Golomb HM, Vokes EE.
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Revisiting metronomic vinorelbine with mathematical modelling: a Phase I trial in lung cancer.
    Barlesi F, Deyme L, Imbs DC, Cousin E, Barbolosi M, Bonnet S, Tomasini P, Greillier L, Galloux M, Testot-Ferry A, Pelletier A, André N, Ciccolini J, Barbolosi D.
    Cancer Chemother Pharmacol; 2022 Aug; 90(2):149-160. PubMed ID: 35867144
    [Abstract] [Full Text] [Related]

  • 24. Low-dose metronomic oral administration of vinorelbine in the first-line treatment of elderly patients with metastatic breast cancer.
    Addeo R, Sgambato A, Cennamo G, Montella L, Faiola V, Abbruzzese A, Capasso E, Leo L, Botti G, Caraglia M, Del Prete S.
    Clin Breast Cancer; 2010 Aug 01; 10(4):301-6. PubMed ID: 20705563
    [Abstract] [Full Text] [Related]

  • 25. Metronomic scheduling: the future of chemotherapy?
    Gasparini G.
    Lancet Oncol; 2001 Dec 01; 2(12):733-40. PubMed ID: 11902515
    [Abstract] [Full Text] [Related]

  • 26. Metronomic chemotherapy for advanced breast cancer patients.
    Cazzaniga ME, Dionisio MR, Riva F.
    Cancer Lett; 2017 Aug 01; 400():252-258. PubMed ID: 28017894
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Anti-angiogenic treatment of breast cancer using metronomic low-dose chemotherapy.
    Munoz R, Shaked Y, Bertolini F, Emmenegger U, Man S, Kerbel RS.
    Breast; 2005 Dec 01; 14(6):466-79. PubMed ID: 16199161
    [Abstract] [Full Text] [Related]

  • 29. Phase I evaluation of oral and intravenous vinorelbine in pediatric cancer patients: a report from the Children's Oncology Group.
    Johansen M, Kuttesch J, Bleyer WA, Krailo M, Ames M, Madden T.
    Clin Cancer Res; 2006 Jan 15; 12(2):516-22. PubMed ID: 16428494
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. A pilot study of docetaxel and trofosfamide as second-line 'metronomic' chemotherapy in the treatment of metastatic non-small cell lung cancer (NSCLC).
    Görn M, Habermann CR, Anige M, Thöm I, Schuch G, Andritzky B, Brandl S, Burkholder I, Edler L, Hossfeld DK, Bokemeyer C, Laack E.
    Onkologie; 2008 Apr 15; 31(4):185-9. PubMed ID: 18418020
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Dose-dependent bidirectional pharmacological effects of vinorelbine-based metronomic combination chemotherapy on tumor growth and metastasis and mechanisms in melanoma mouse model.
    Liu H, Zheng Q, Li M, Kou J, Wei J, Feng W.
    Fundam Clin Pharmacol; 2024 Feb 15; 38(1):99-112. PubMed ID: 37458143
    [Abstract] [Full Text] [Related]

  • 34. A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design.
    Vokes EE, Drinkard LC, Samuels BL, Hoffman PC, Watson S, Bitran JD, Haraf DJ, Ferguson MF, Golomb HM.
    Semin Oncol; 1994 Oct 15; 21(5 Suppl 10):79-83; discussion 83-4. PubMed ID: 7973772
    [Abstract] [Full Text] [Related]

  • 35. [Metronomic Chemotherapy--A New Path to Treat Advanced Non-small Cell Lung Cancer].
    Zhang S, Liu J, Cheng Y.
    Zhongguo Fei Ai Za Zhi; 2015 Apr 15; 18(4):232-9. PubMed ID: 25936888
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec 15; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 38. Pharmacokinetics of metronomic chemotherapy: a neglected but crucial aspect.
    Bocci G, Kerbel RS.
    Nat Rev Clin Oncol; 2016 Nov 15; 13(11):659-673. PubMed ID: 27184418
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Phase II trial of oral vinorelbine in combination with cisplatin followed by consolidation therapy with oral vinorelbine in advanced NSCLC.
    Lena MD, Ramlau R, Hansen O, Lorusso V, Wagner L, Barni S, Cristovao MM, Huber R, Alberola V, Mitrovic M, Colin C, Gasmi J.
    Lung Cancer; 2005 Apr 15; 48(1):129-35. PubMed ID: 15777980
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.